Revvity (RVTY) Raw Materials (2011 - 2016)
Revvity's (RVTY) quarterly Raw Materials came in at $99.0 million in Q1 2016, up 2.93% on a YoY basis from $96.2 million in Q1 2015, and up 2.93% quarter-over-quarter from $96.2 million in Q4 2014.
Powered by 
Analysis
Revvity (RVTY) Raw Materials (2011 - 2016) Analysis & Trends
Revvity (RVTY) has reported Raw Materials for 3 consecutive years, with $99.0 million the latest figure, recorded in Q1 2016.
- For the quarter ending Q1 2016, Raw Materials rose 2.93% year-over-year to $99.0 million; the trailing twelve-month figure through Jan 2016 stood at $99.0 million (up 2.93% YoY), and the FY2016 full-year result was $99.0 million, up 2.93% from the prior year.
- Raw Materials climbed to $99.0 million in Q1 2016 per RVTY's latest filing, from $96.2 million in the prior quarter.
- Across five years, Raw Materials topped out at $99.0 million in Q1 2016 and bottomed at $96.2 million in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 3, 2016 | 98.98 Mn |
| Dec 28, 2014 | 96.17 Mn |
| Jul 3, 2011 | 73.91 Mn |
| Jan 2, 2011 | 70.47 Mn |